Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Psychoneuroendocrinology. 2013 Feb 11;38(9):1553–1564. doi: 10.1016/j.psyneuen.2013.01.004

Table 7.

Impact of LFD or HFD feeding on gene expression in cerebral hippocampus, hypothalamus and cortex after 1 or 3 weeks of feeding.

1 week 3 weeks


Gene LFD HFD LFD HFD

Hypothalamus IL-1α* 1.000 ± 0.161 0.955 ± 0.102 0.717 ± 0.151 0.865 ± 0.108
IL-1β* 1.000 ± 0.239 1.005 ± 0.154 0.744 ± 0.201 0.729 ± 0.186
IL-1R1* 1.000 ± 0.143 0.915 ± 0.173 1.090 ± 0.189 1.420 ± 0.207
1IL-1R2 1.000 ± 0.123 0.909 ± 0.185 1.101 ± 0.105 0.844 ± 0.215
IL-1RA 1.000 ± 0.288 0.894 ± 0.124 0.984 ± 0.209 1.235 ± 0.379
TNF-α 1.000 ± 0.207 0.901 ± 0.126 0.867 ± 0.109 0.928 ± 0.177
IL-6# 1.000 ± 0.114 0.942 ± 0.066 1.215 ± 0.071 0.963 ± 0.103
CD45* 1.000 ± 0.096 1.006 ± 0.028 0.892 ± 0.080 0.859 ± 0.094
CD11b* 1.000 ± 0.078 0.977 ± 0.045 0.832 ± 0.037 0.853 ± 0.065
F4/80* 1.000 ± 0.065 0.947 ± 0.062 0.793 ± 0.072 0.721 ± 0.057
NGF* 1.000 ± 0.081 1.006 ± 0.128 0.814 ± 0.070 0.839 ± 0.070
BDNF* 1.000 ± 0.115 1.088 ± 0.133 0.746 ± 0.124 0.649 ± 0.109

Hypothalamus IL-1α* 1.000 ± 0.133 1.003 ± 0.114 0.743 ± 0.115 0.799 ± 0.106
IL-1β 1.000 ± 0.274 0.946 ± 0.143 0.771 ± 0.207 0.979 ± 0.073
1IL-1R2 1.000 ± 0.951 0.729 ± 0.119 0.609 ± 0.724 0.724 ± 0.471
IL-1RA* 1.000 ± 0.349 0.882 ± 0.249 0.632 ± 0.220 0.454 ± 0.125
TNF-α* 1.000 ± 0.172 0.835 ± 0.212 0.649 ± 0.205 0.710 ± 0.126
1IL-6+ 1.000 ± 0.123a 1.054 ± 0.161a,b 1.298 ± 0.069b 0.923 ± 0.109a
CD45* 1.000 ± 0.062 1.029 ± 0.072 0.850 ± 0.044 0.806 ± 0.049
CD11b* 1.000 ± 0.081 1.031 ± 0.085 0.913 ± 0.059 0.909 ± 0.095
1F4/80* 1.000 ± 0.043 0.957 ± 0.060 0.736 ± 0.095 0.659 ± 0.043
NGF 1.000 ± 0.216 0.768 ± 0.153 1.023 ± 0.288 0.800 ± 0.183
BDNF 1.000 ± 0.100 0.891 ± 0.124 0.876 ± 0.055 0.914 ± 0.087

Cortex IL-1α# 1.000 ± 0.102 1.050 ± 0.069 0.844 ± 0.126 1.049 ± 0.084
1IL-1β 1.000 ± 0.345 1.240 ± 0.077 1.083 ± 0.211 1.437 ± 0.131
IL-1R1 1.000 ± 0.255 1.069 ± 0.116 0.868 ± 0.278 1.208 ± 0.201
IL-1R2 1.000 ± 0.063 0.955 ± 0.064 0.976 ± 0.084 0.962 ± 0.103
IL-1RA# 1.000 ± 0.178 1.153 ± 0.104 0.935 ± 0.115 1.212 ± 0.146
TNF-α 1.000 ± 0.099 0.888 ± 0.104 0.903 ± 0.104 0.991 ± 0.150
1IL-6 1.000 ± 0.139 1.042 ± 0.064 1.273 ± 0.120 1.068 ± 0.115
1CD45 1.000 ± 0.071 1.115 ± 0.067 0.721 ± 0.629 1.069 ± 0.060
CD11b 1.000 ± 0.079 1.056 ± 0.073 0.981 ± 0.050 1.050 ± 0.075
F4/80 1.000 ± 0.069 1.015 ± 0.071 0.960 ± 0.075 0.989 ± 0.076
NGF* 1.000 ± 0.067 0.884 ± 0.051 0.765 ± 0.053 0.761 ± 0.071
BDNF+ 1.000 ± 0.084a 0.870 ± 0.037b 0.830 ± 0.049b 0.950 ± 0.063a

Results are expressed as relative fold change in mRNA expression (mRNA), means ± SEM.; n = 6–8. Results within individual rows without a common superscript letter are significantly different.

*

P < 0.05, significant main effect of time.

#

P < 0.05, significant main effect of diet.

+

P < 0.05, significant time-diet interaction.

1

Friedman’s two-way ANOVA for non-parametric data used for analysis.

HHS Vulnerability Disclosure